An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
- 1 June 2021
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 84 (6) , 1652-1666
Abstract
No abstract availableKeywords
Funding Information
- University of British Columbia
This publication has 168 references indexed in Scilit:
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirusProceedings of the National Academy of Sciences, 2013
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapyAnnals of the Rheumatic Diseases, 2013
- Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2012
- Treatment with the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere with the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center StudyClinical and Vaccine Immunology, 2012
- Influenza vaccination responses in human systemic lupus erythematosus: Impact of clinical and demographic featuresArthritis & Rheumatism, 2011
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximabVaccine, 2011
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatmentArthritis Research & Therapy, 2010
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximabArthritis & Rheumatism, 2009
- Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2007